Kidney cancer mortality: Fifty-year latency patterns related to arsenic exposure

Epidemiology

Volumn 21, Issue 1, 2010, Pages 103-108

  Yuan, Yan ^a   Marshall, Guillermo ^b,c   Ferreccio, Catterina ^b   Steinmaus, Craig ^a,d   Liaw, Jane ^a   Bates, Michael ^a   Smith, Allan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; DEATH CERTIFICATE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; ARSENIC POISONING; CHILE; DATABASES AS TOPIC; DEATH CERTIFICATES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MORTALITY; REACTION TIME;

EID: 73849122839     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181c21e46     Document Type: Article

References (35)

1. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985;45:5895-5899.
2. Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet. 1988;1:414-415.
3. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8:452-460.
4. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989;130:1123-1132.
5. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990;50:5470-5474.
6. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992;66:888-892.
7. Tsai SM, Wang TN, Ko YC. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 1999;54: 186-193.
8. Yang CY, Chiu HF, Wu TN, Chuang HY, Ho SC. Reduction in kidney cancer mortality following installation of a tap water supply system in an arsenic-endemic area of Taiwan. Arch Environ Health. 2004;59:484-488.
9. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 1998;27:561-569.
10. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 1995;141:198-209.
11. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect. 1999;107:705-710.
12. Smith AH, Goycolea M, Haque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998;147:660-669.
13. International Agency for Research on Cancer. Some drinking-water disinfectants and contaminants, including arsenic. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 84. Lyon, France: World Health Organization; 2004.
14. Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst. 2007;99:920-928.
15. Yuan Y, Marshall G, Ferreccio C, et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol. 2007;166:1381-1391.
16. Smith AH, Marshall G, Yuan Y, et al. Increased mortality from lung cancer and bronchiectasis in young adults following exposure to arsenic in utero and early childhood. Environ Health Perspect. 2006;114:1293-1296.
17. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. Increased childhood liver cancer mortality and arsenic in drinking water in Northern Chile. Cancer Epidemiol Biomarkers Prev. 2008; 17:1982-1987.
18. Ferreccio C, Gonzalez CA, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology. 2000;11:673-679.
19. Hopenhayn C, Ferreccio C, Browning SR, et al. Arsenic exposure from drinking water and birth weight. Epidemiology. 2003;14:593-602.
20. Instituto Nacional de Estadistica y Censos. Censo '91. Censo Nacional de Poblacion y Vivienda 1991. Resultados Definitivos-Caracteristicas Seleccionadas Cordoba Serie B No 4. Buenos Aires, Argentina: Republica Argentina Ministerio de Economia y Obras y Servicios Publicos Secretaria de Programacion Economica; 1993.
21. CASEN. Ministerio de Planificacion y Cooperacion Nacional Republica de Chile. 15th ed. Santiago, Chile: Illa Encuestra CASEN (Caracterizacion Socio Economica Nacional); 1992.
22. Castillo B, Mardones G. Medical certification of deaths in the health services of Chile [in Spanish]. Rev Med Chil. 1986;114:693-700.
23. Kiemeney L, Van Berkel H, Witjes JA, Sonke GS, Debruyne FM, Straatman H. Kidney cancer mortality in the Netherlands, 1950-1994: prediction of a decreasing trend. J Epidemiol Biostat. 1999;4:303-311.
24. Chow WO, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631.
25. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331-1334.
26. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101:949-958.
27. Waalkes MP, Keefer LK, Diwan BA. Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol Appl Pharmacol. 2000;166:24-35.
28. Waalkes MP, Liu J, Diwan BA. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol. 2007;222:271-280.
29. Morgenstern H, Thomas D. Principles of study design in environmental epidemiology. Environ Health Perspect. 1993;101:23-38.
30. Soto R, Torche A. Spatial inequality, migration, and economic growth in Chile. Cuadernos de Economía. 2004;41:401-424.
31. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology. 1997;8:545-550.
32. Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol. 2001;153:411-418.
33. Moore LE, Wilson RT, Campleman SL. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest. 2005;23:240-255.
34. Adam KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168: 268-277.
35. Gobierno de Chile, Ministerio de salud. Resultados 1 encuesta de salud, Chile 2003. Available at: http://epi.minsal.cl/epi/html/invest/ENS/Informe FinalENS.pdf. Accessed December 15, 2008